Sepsis, thrombosis and organ dysfunction

Area of Science:

• Pathophysiology of sepsis
• Hemostasis and thrombosis
• Inflammatory response

Background:

• Sepsis involves complex hemostatic changes, from hypercoagulability to disseminated intravascular coagulation (DIC).
• The host's inflammatory response to infection drives critical changes in coagulation and fibrinolysis.
• Microvascular thrombosis and ischemia contribute to tissue injury and multiple organ dysfunction syndrome (MODS).

Purpose of the Study:

• To elucidate the mechanisms underlying sepsis-associated DIC and MODS.
• To explore the role of inflammatory mediators and extracellular nuclear materials in sepsis pathogenesis.
• To identify potential therapeutic targets for severe sepsis management.

Main Methods:

• Review of current literature on sepsis, coagulation, and inflammation.
• Analysis of the roles of tissue factor (TF), anticoagulant pathways, and fibrinolysis.
• Investigation of extracellular nuclear materials like HMGB-1 and histones in sepsis.

Main Results:

• Aberrant TF expression, impaired anticoagulant pathways, and suppressed fibrinolysis contribute to excessive thrombin formation and fibrin deposition.
• Dysfunctional endothelial cells (ECs) and overproduction of PAI-1 and TAFI impair natural anticoagulation and fibrinolysis.
• Extracellular nuclear materials (HMGB-1, histones) act as late mediators, promoting inflammation, coagulation, cell death, and MODS.

Conclusions:

• Understanding the interplay between inflammation, coagulation, and extracellular nuclear materials is crucial for managing sepsis-induced DIC and MODS.
• These insights may pave the way for novel therapeutic strategies targeting key mediators in severe sepsis.
• Targeting extracellular nuclear materials could offer a new approach to mitigate sepsis complications.